Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study to Evaluate ONM100, an Intraoperative Fluor Imaging Agent for the Detection of Peri Mets

ClinicalTrials.gov ID: NCT04950166

Public ClinicalTrials.gov record NCT04950166. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 16, 2026, 7:25 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Open-Label Study to Evaluate the Performance and Safety of ONM100, an Intraoperative Fluor Imaging Agent for the Detection of Peritoneal Mets

Study identification

NCT ID
NCT04950166
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
OncoNano Medicine, Inc.
Industry
Enrollment
51 participants

Conditions and interventions

Interventions

  • pegsitacianine Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 29, 2021
Primary completion
Dec 28, 2022
Completion
Jan 19, 2023
Last update posted
Nov 7, 2024

2021 – 2023

United States locations

U.S. sites
5
U.S. states
4
U.S. cities
5
Facility City State ZIP Site status
Wake Forest Baptist Health Winston-Salem North Carolina 27157
The Ohio State University Wexner Medical Center / James Cancer Hospital Columbus Ohio 43201
Perelman School of Medicine, University of Pennsylvania Philadelphia Pennsylvania 19146
AHN Cancer Institute, West Penn Hospital Pittsburgh Pennsylvania 15212
The University of Texas MD Anderson Cancer Center Houston Texas 77030

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04950166, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 7, 2024 · Synced May 16, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04950166 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →